The trans-ancestral genomic architecture of glycemic traits.
Level 3 - non-randomized controlled study
Meta-analysis of observational cross-sectional genome-wide association studies (level by design analogy).
PubMed 34059833 · doi:10.1038/s41588-021-00852-9
What was done
The authors aggregated genome-wide association studies across up to 281,416 individuals without diabetes (30% non-European ancestry). They conducted single-ancestry and trans-ancestry meta-analyses, fine-mapping, and functional genomic analyses across four glycemic traits: fasting glucose, 2-hour glucose after an oral glucose challenge, glycated hemoglobin, and fasting insulin.
What was found
The meta-analyses identified 242 loci (99 novel; P < 5 × 10⁻⁸), 80% of which showed no significant evidence of between-ancestry heterogeneity. European-only analyses of equivalent sample size would have missed 24 of the novel loci. Trans-ancestry fine-mapping reduced the median number of variants in 99% credible sets by 37.5% compared to single-ancestry analyses.
Why it matters
This study shows that the genetic architecture of glycemic traits is largely shared across ancestries and demonstrates that including diverse populations substantially improves variant discovery and fine-mapping resolution for cardiometabolic traits.
Limits
The study was restricted to individuals without diabetes, so mechanisms unique to clinical disease were not captured. Individuals of European ancestry still comprised 70% of the cohort. Findings reflect statistical associations and fine-mapping estimates rather than direct functional experimental validation.
Cited by
- contradicts Approximately 6,000 genes are involved in regulating blood sugar.